whitepaper Beyond the Lab: Stem cell research 23 January 2025 | By Drug Target Review Download our latest report to discover how stem cell research is revolutionising treatments for chronic diseases, cancer and regenerative medicine.
news New agreement to progress cardiovascular disease research 26 July 2024 | By Drug Target Review The agreement between Cartherics, The University of Sydney and The University of Queensland will further stem cell-derived heart muscle therapy for heart failure.
whitepaper Beyond the lab: stem cell research 29 January 2024 | By Drug Target Review Download this report to discover more about human derived induced pluripotent stem cells (hiPSCs), the suitability of NK cells for cancer therapy and the latest research into Alzheimer’s disease.
article CAR-NK cells: promising for cancer therapy 17 November 2023 | By Aleta Pupovac (Carthetics), Dr Huimin Cao (Cartherics), Professor Alan Trounson (Cartherics) The suitability of NK cells for cancer therapy has been challenged by some investor and business interests because of limited efficacy data, is this a valid belief at the present stage of development of the immune therapy field?